RGT 3.33% 29.0¢ argent biopharma limited

Ann: Additional Information on Ground-breaking Research, page-2

  1. 166 Posts.
    lightbulb Created with Sketch. 50
    "Based on the glioblastoma cells and stem cells response, the Company will start to design a clinical study in humans, to treat patients with the most effective combinations of cannabinoids to reduce tumour volume"

    Now able to be tested on humans, the results of this could be massive!

    GLTAH
    Last edited by alaedean: 29/07/19
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
-0.010(3.33%)
Mkt cap ! $14.03M
Open High Low Value Volume
28.5¢ 29.0¢ 28.5¢ $737 2.575K

Buyers (Bids)

No. Vol. Price($)
2 2827 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 2307 1
View Market Depth
Last trade - 14.01pm 22/07/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.